Molecular insights into cancer invasion: strategies for prevention and intervention.
暂无分享,去创建一个
E. Kohn | L. Liotta | L A Liotta | E C Kohn
[1] H. Sato,et al. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. , 1993, The Journal of biological chemistry.
[2] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[3] R. Schultz,et al. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. , 1988, Cancer research.
[4] E. Kohn,et al. In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates. , 1992, Cancer research.
[5] L. Liotta,et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.
[6] C. Harris,et al. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. , 1989, Cancer research.
[7] M. Hung,et al. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A. , 1993, Cancer research.
[8] E. Kohn,et al. Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A). , 1994, The Journal of biological chemistry.
[9] G. Schwartz,et al. Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. , 1993, Journal of the National Cancer Institute.
[10] G. V. Vande Woude,et al. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[11] L. Matrisian,et al. Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.
[12] Jack P. Witty,et al. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. , 1994, Cancer research.
[13] V. Schirrmacher. Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. , 1985, Advances in cancer research.
[14] J. Reynolds,et al. An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. , 1981, The Biochemical journal.
[15] E. Kohn,et al. The antiproliferative and antimetastatic compound L651582 inhibits muscarinic acetylcholine receptor-stimulated calcium influx and arachidonic acid release. , 1991, The Journal of pharmacology and experimental therapeutics.
[16] L. Liotta,et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.
[17] H. Sato,et al. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. , 1993, Oncogene.
[18] N. Kohl,et al. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic , 1994, Cell.
[19] L. Liotta,et al. Tumor cell invasion inhibited by TIMP-2. , 1991, Journal of the National Cancer Institute.
[20] G. Prendergast,et al. Pathways of Ras function: connections to the actin cytoskeleton. , 1993, Advances in cancer research.
[21] D. Rifkin,et al. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade , 1986, Cell.
[22] E. Clementi,et al. Ca2+ influx following receptor activation. , 1991, Trends in pharmacological sciences.
[23] T. Stossel. On the crawling of animal cells. , 1993, Science.
[24] L. Liotta,et al. Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. , 1989, The Journal of biological chemistry.
[25] D. Rifkin,et al. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases , 1989, The Journal of cell biology.
[26] G. Nicolson. Gene expression, cellular diversification and tumor progression to the metastatic phenotype , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.
[27] P. Waterhouse,et al. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. , 1989, Science.
[28] L. Liotta,et al. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. , 1974, Cancer research.
[29] E. Kohn,et al. Structure-function analysis of signal and growth inhibition by carboxyamido-triazole, CAI. , 1994, Cancer research.
[30] H. Gallager,et al. The study of mammary carcinoma by mammography and whole organ sectioning early observations , 1969, Cancer.
[31] E. Kohn,et al. L651582: a novel antiproliferative and antimetastasis agent. , 1990, Journal of the National Cancer Institute.
[32] C. Bucana,et al. Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. , 1990, Journal of the National Cancer Institute.
[33] D. Y. Wu,et al. Regulated tyrosine phosphorylation at the tips of growth cone filopodia , 1993, The Journal of cell biology.
[34] A. Eisen,et al. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[35] A. Eisen,et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.
[36] M. Reidy,et al. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. , 1994, Circulation research.
[37] L. Liotta,et al. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. , 1990, The American journal of pathology.
[38] F. Balkwill,et al. A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. , 1993, Cancer research.
[39] L. Liotta,et al. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. , 1989, The Journal of biological chemistry.
[40] E. Galleher,et al. CIRCULATING "CANCER CELLS". , 1964, JAMA.
[41] R. Hoffman,et al. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. , 1994, Cancer research.
[42] R. Greenberg,et al. Geometry, growth rates, and duration of cancer and carcinoma in situ of the breast before detection by screening. , 1986, Cancer research.
[43] K. Tryggvason,et al. Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. , 1984, The Journal of biological chemistry.
[44] Motoharu Seiki,et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.
[45] R. Irvine,et al. Inositol phosphates and Ca2+ entry: toward a proliferation or a simplification? , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] L. Wattenberg. Prevention--therapy--basic science and the resolution of the cancer problem. , 1993, Cancer research.
[47] G P Siegal,et al. Loss of basement membrane components by invasive tumors but not by their benign counterparts. , 1983, Laboratory investigation; a journal of technical methods and pathology.
[48] M. Hendrix,et al. Role of the alpha v beta 3 integrin in human melanoma cell invasion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[49] L. Liotta,et al. Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. , 1982, Journal of the National Cancer Institute.
[50] Two phases of pseudopod protrusion in tumor cells revealed by a micropipette. , 1994, Microvascular research.
[51] L. Liotta,et al. Partial purification and characterization of a neutral protease which cleaves type IV collagen. , 1981, Biochemistry.
[52] W. Stetler-Stevenson,et al. Inhibition of tumor cell invasion by a highly conserved peptide sequence from the matrix metalloproteinase enzyme prosegment. , 1992, Cancer research.
[53] F. Blasi. Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness , 1993 .
[54] L. Matrisian,et al. TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence , 1990, Cell.
[55] V. Steele,et al. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. , 1994, Cancer research.
[56] Z. Werb,et al. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution , 1992, The Journal of cell biology.
[57] L. Liotta,et al. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. , 1995, Cancer research.
[58] E. Kohn,et al. Muscarinic receptor-mediated tyrosine phosphorylation of phospholipase C-gamma. An alternative mechanism for cholinergic-induced phosphoinositide breakdown. , 1993, The Journal of biological chemistry.
[59] N. Fotouhi,et al. Potent peptide inhibitors of stromelysin based on the prodomain region of matrix metalloproteinases. , 1994, The Journal of biological chemistry.
[60] M. Kéramidas,et al. Tyrosine protein kinase activity of the EGF receptor is required to induce activation of receptor-operated calcium channels. , 1989, Biochemical and biophysical research communications.
[61] D. Grobelny,et al. Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide. , 1994, Cancer research.
[62] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[63] L. Liotta,et al. Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration , 1987, Nature.
[64] G. Prendergast,et al. Negative growth selection against rodent fibroblasts targeted for genetic inhibition of farnesyl transferase. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[65] G. Powis. Drugs active against growth factor and oncogene phosphatidylinositol signalling pathways. , 1992, Seminars in cancer biology.
[66] L. Liotta,et al. Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. , 1986, Science.
[67] R. Miskin,et al. Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells , 1989, Molecular and cellular biology.
[68] P. Janmey,et al. Phosphoinositides and calcium as regulators of cellular actin assembly and disassembly. , 1994, Annual review of physiology.
[69] L. Liotta,et al. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.
[70] L. Liotta,et al. Type IV collagen stimulates an increase in intracellular calcium. Potential role in tumor cell motility. , 1992, The Journal of biological chemistry.
[71] J. Sheffield,et al. Inhibition of retinal growth cone activity by specific metalloproteinase inhibitors in vitro , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.
[72] E. Kohn,et al. Angiogenesis: role of calcium-mediated signal transduction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[73] H. V. Van Wart,et al. Synthetic inhibitors of bacterial and mammalian interstitial collagenases. , 1992, Progress in medicinal chemistry.
[74] R Bedwani,et al. Management and survival of female patients with “minimal” breast cancer: As observed in the long‐term and short‐term surveys of the american college of surgeons , 1981, Cancer.
[75] Z. Werb,et al. Signal transduction by integrin receptors for extracellular matrix: Cooperative processing of extracellular information , 1992, Current Biology.
[76] H. Lu,et al. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. , 1989, The Journal of biological chemistry.
[77] L. Liotta,et al. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. , 1991, Cancer research.
[78] J. Condeelis,et al. Life at the leading edge: the formation of cell protrusions. , 1993, Annual review of cell biology.
[79] L. Liotta,et al. Cloning and characterization of human tumor cell interstitial collagenase. , 1990, Cancer research.
[80] R. Hynes,et al. Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons , 1992, Cell.
[81] H. Shimada,et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. , 1992, Cancer research.